基于介质干细胞治疗炎症性肠病的治疗潜力:目前的进展和未来的前景
1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, PR China; Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, PR China; No.1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210029, PR China.
Biochemical and biophysical research communications
|November 19, 2025
概括
介质细胞干细胞 (MSC) 通过减少炎症和再生组织来治疗炎症性肠病 (IBD) 是有前途的. 优化MSC指导和将其与传统中医 (TCM) 整合,可能会提高IBD的治疗结果.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
背景情况:
- 炎症性肠病 (IBD) 是一种具有复杂病因和有限治疗疗效的慢性胃肠疾病.
- 目前的治疗方法,如5-aminosalicylic 酸 (5-ASA),往往提供不理想的结果.
- 介酶干细胞 (MSC) 由于其再生和免疫调节特性,为IBD提供潜在的治疗益处.
研究的目的:
- 审查介质干细胞 (MSC) 在治疗炎症性肠病 (IBD) 中的作用.
- 探索优化MSC指导效应的策略,以加强IBD治疗.
- 检查传统中医 (TCM) 与基于MSC的IBD治疗方法的整合.
主要方法:
- 文献综述综合了IBD中MSCs的当前知识.
- 对MSC定位机制及其调节的研究分析.
- 审查关于TCM在调节IBD的MSC行为中的作用的研究.
主要成果:
- MSCs可以调节T细胞种群并促进组织修复,为IBD提供了一种新的治疗途径.
- 调节MSC的指导效应对于最大限度地发挥其在IBD中的治疗潜力至关重要.
- 在治疗IBD时,TCM干预措施在调节MSC定位和差异化方面表现有前途.
结论:
- 优化MSC定位是提高它们在治疗炎症性肠病中的疗效的关键.
- 结合MSC治疗与TCM,为未来IBD管理提供了一个有希望的策略.
- 对MSC-TCM整合的进一步研究可能会导致更有效的IBD治疗方法.
相关概念视频
01:19Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
452
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
452
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
620
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
620
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
469
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
469
01:21Inflammatory Bowel Disease V: Surgical Management
429
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
429
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
465
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
465